论文部分内容阅读
泰能(Imiperem)系由美国近期开发的新型β-内酰胺类的高效杀菌剂。该药虽已广泛应用于治疗各种感染,但对有肺部严重感染须入呼吸重症监护室(RICU)的患者的疗效观察报道不多,为此我们作了观察。1 材料与方法1.1 病例选择本组36例均为肺部有严重感染且已有青霉素、链霉素、红霉
Imiperem is a new β-lactam fungicide recently developed in the United States. Although widely used in the treatment of various infections, the efficacy of this drug is poorly documented in patients with severe lung infections who have to enter the Respiratory Care Unit (RICU). 1 Materials and Methods 1.1 Case Selection 36 cases of this group are serious pulmonary infection and have penicillin, streptomycin, erythromycin